Rare diseases
Investigational molecules
Locations
9 HaTa'asiya, 4365405
Urogen Pharma Ltd. focuses on cancers of the urinary tract, with particular attention to low-grade upper tract urothelial cancer and non-muscle invasive bladder cancer.
The company’s clinical portfolio is centered on disease areas where local tumor control and bladder-preserving treatment strategies are central therapeutic interests.
Urogen Pharma Ltd. runs clinical trials in conditions such as Bladder cancer, Transitional cell cancer of the renal pelvis and ureter, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaBulgaria
AustriaBulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
